The estimated Net Worth of Joseph Carleone is at least $7.92 Million dollars as of 14 December 2023. Joseph Carleone owns over 9,612 units of Sensient Technologies stock worth over $7,626,748 and over the last 10 years he sold SXT stock worth over $0. In addition, he makes $294,056 as Independent Director at Sensient Technologies.
Joseph has made over 12 trades of the Sensient Technologies stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 9,612 units of SXT stock worth $707,828 on 14 December 2023.
The largest trade he's ever made was buying 44,445 units of Sensient Technologies stock on 15 February 2018 worth over $100,001. On average, Joseph trades about 2,282 units every 33 days since 2014. As of 14 December 2023 he still owns at least 103,568 units of Sensient Technologies stock.
You can see the complete history of Joseph Carleone stock trades at the bottom of the page.
Dr. Joseph Carleone Ph.D. serves as Independent Director of the Company. Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC (since December 2015), a leading manufacturer of pharmaceutical active ingredients. Prior to this position, Dr. Carleone was President and Chief Executive Officer of American Pacific Corporation (2010 to 2015), a leading custom manufacturer of fine and specialty chemicals and propulsion products. While at American Pacific Corporation, he also served as President and Chief Operating Officer (2006 to 2009), as a director (2006 to 2015), and as Chairman of the Board (March 2013 to February 2014, when it was acquired by H.I.G. Capital, LLC). Dr. Carleone has also served or currently serves as an officer and/or a director of several directly or indirectly wholly-owned subsidiaries of American Pacific Corporation. Since November 27, 2017, Dr. Carleone has served as a director of Avid Bioservices, Inc. (formerly known as Peregrine Pharmaceuticals, Inc.) (NASDAQ: PPHM). After his election as a director, he was named non-executive Chairman of Avid Bioservices’ Board of Directors. Avid Bioservices is a clinical stage biopharmaceutical company focused on developing therapeutics to stimulate the body’s immune system to fight cancer. Dr. Carleone received his bachelor’s degree in Mechanical Engineering from Drexel University, Philadelphia, Pennsylvania, in 1968; his masters’ degree in Applied Mechanics from Drexel University in 1970; and his doctorate degree in Applied Mechanics from Drexel University in 1972.
As the Independent Director of Sensient Technologies, the total compensation of Joseph Carleone at Sensient Technologies is $294,056. There are 10 executives at Sensient Technologies getting paid more, with Paul Manning having the highest compensation of $5,819,140.
Joseph Carleone is 74, he's been the Independent Director of Sensient Technologies since 2014. There are 2 older and 22 younger executives at Sensient Technologies. The oldest executive at Sensient Technologies Corp. is Edward Cichurski, 78, who is the Independent Director.
Joseph's mailing address filed with the SEC is 777 EAST WISCONSIN AVENUE, , MILWAUKEE, WI, 53202.
Over the last 21 years, insiders at Sensient Technologies have traded over $506,130,949 worth of Sensient Technologies stock and bought 2,091,019 units worth $179,367,326 . The most active insiders traders include Investment Pte Ltd Freemont..., Investment Pte Ltd Haldor F..., and Kenneth P Manning. On average, Sensient Technologies executives and independent directors trade stock every 18 days with the average trade being worth of $2,140,788. The most recent stock trade was executed by Gebhardt Deborah Mc Keithan on 14 August 2024, trading 2,000 units of SXT stock currently worth $142,160.
we bring life to products. our name communicates what we do: enhance sensory experiences through specialized ingredients, delivered through proprietary technologies. sensient technologies corporation is a leading global developer, manufacturer and marketer of colors, flavors and fragrances. sensient uses advanced proprietary technologies at facilities around the world to produce a broad range of innovative products. we provide customized food and beverage systems, pharmaceutical colors and coatings, cosmetic and personal care formulations, inkjet and specialty inks and colors, and other fine chemicals to most of the world’s best-known consumer and industrial companies. sensient is in the business of innovation. all of our units emphasize technology-based products that provide a competitive advantage. we serve our customers by continuously delivering innovation and streamlined product-development expertise, helping them extend their existing brands as well as create new products. learn
Sensient Technologies executives and other stock owners filed with the SEC include: